brandy

PALM BEACH GARDENS, Fla., May 19, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Toro Lateral (Toro-L) …

Accelus Receives U.S. FDA 510(k) Clearance for its Toro-L Interbody Fusion System Read More »

PALM BEACH GARDENS, Fla., May 12, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its FlareHawk TiHawk™11 Interbody …

Accelus Receives U.S. FDA 510(k) Clearance for its FlareHawk TiHawk11 Interbody Fusion System Read More »

TiHawk7 combines ultra-low 7mm insertion profile with strong titanium/PEEK adhesion while still allowing for radiographic verification of fusion PALM BEACH GARDENS, Fla., May 5, 2022 (GLOBE NEWSWIRE) – Accelus, a medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced the alpha launch …

Accelus Launches TiHawk7™ Titanium-Bonded Multidirectionally Expanding Interbody Cage to Support Endoscopic and MIS Lumbar Fusion Procedures Read More »

Leading medical technology company recognized for employee engagement and culture PALM BEACH GARDENS, Fla., May 02, 2022 (GLOBE NEWSWIRE) — Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced that it has been recognized by The Sun Sentinel …

Sun Sentinel Names Accelus a Winner of the South Florida Top Workplaces 2022 Award Read More »

PALM BEACH GARDENS, Fla., April 21, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced the successful completion of the first surgery integrating its Remi™ Robotic Navigation, LineSider® Spinal System, and FlareHawk® Expandable Interbody …

Accelus Announces First Procedure Integrating Remi Robotic Navigation System, LineSider Spinal System, and FlareHawk Expandable Interbody Fusion Device Technologies Read More »

Distinguished neurosurgeon-inventor to lead continued development of Accelus’s Remi™ Robotic Navigation System PALM BEACH GARDENS, Fla., April 18, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced the appointment of Kevin Foley, MD, as …

Accelus Appoints Kevin Foley, MD as Chief Robotics Officer Read More »

Innovative new robotic targeting and navigation system provides precision, accessibility Palm Beach Gardens, FL / Summit, NJ, March 10, 2022 – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced the successful completion of the first cases utilizing …

Accelus Announces Successful First Surgeries Using Remi Robotic Navigation System with LineSider Spinal System Read More »

Transaction expected to combine Accelus and CHP Merger Corp., a leading healthcare-focused SPAC. The pro-forma enterprise value of the business combination would be approximately $482 million. Chris Walsh, Accelus CEO and Co-Founder, will become CEO of the combined company, Accelus. Mr. Walsh has 25 years of experience at leading spinal health companies, including Stryker and …

Accelus, an Emerging Leader in Minimally Invasive Spine Surgery, and CHP Merger Corp. Announce Proposed Business Combination Read More »